Clinical Trials Browser

Phase 2 × Recruiting × fezolinetant × Clear all

NCT06917313 2026-05-06

FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy

Phase 2 Recruiting

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

NCT06972875 2026-02-05

FLASH

Phase 2 Recruiting

Prostatic Neoplasms, Hot Flashes